{"id":"W2979809231","doi":"10.1182/blood.v124.21.519.519","title":"Epic: A Phase 3 Trial of Ponatinib Compared with Imatinib in Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CP-CML)","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Ponatinib; Medicine; Imatinib; Internal medicine; Imatinib mesylate; Myeloid leukemia; Clinical endpoint; Nilotinib; Oncology; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001996146,0.001090094,0.001430759,0.0002712625,0.0003548811,0.0007674836,0.0008029543,0.000991811,0.005914791],"category_scores_gemma":[0.001645609,0.0003133944,0.001206712,0.0003375988,0.0006237419,0.0008487465,0.0005049769,0.002386315,0.0006025643],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005489371,"about_ca_system_score_gemma":0.00093036,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006099694,"about_ca_topic_score_gemma":0.001742624,"domain_scores_codex":[0.9993317,0.0004285336,0.0000287617,0.00008275509,0.00005460865,0.00007372179],"domain_scores_gemma":[0.999255,0.000176009,0.000181981,0.0000571063,0.00005286085,0.0002769711],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9394828,0.01114841,0.003972065,0.0006535379,0.001319189,0.0001499054,0.0001156507,0.001000392,0.005545578,0.0003176412,0.003861259,0.0324336],"study_design_scores_gemma":[0.8845018,0.09835943,0.01236911,0.00003165404,0.0005406053,0.0002072436,0.00003163264,0.0008657583,0.0006594399,0.0002896766,0.00211983,0.00002382907],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.987217,0.002920956,0.0005498335,0.0007720925,0.0001827151,0.002655042,0.001666308,0.00009544391,0.003940525],"genre_scores_gemma":[0.9883162,0.001313697,0.001339848,0.001423533,0.0002167547,0.002087009,0.002528189,0.0000244149,0.002750263],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005914791,"threshold_uncertainty_score":0.01978689,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01277370156602501,"score_gpt":0.2755707507136372,"score_spread":0.2627970491476121,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}